Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
1.710
-0.100 (-5.52%)
Aug 14, 2025, 10:55 AM - Market open

Q32 Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-52.3-47.73-53.74-42.81-37.56
Depreciation & Amortization
0.450.490.50.370.05
Other Amortization
0.20.190.090.10.1
Loss (Gain) From Sale of Assets
---0.02-
Loss (Gain) From Sale of Investments
0.530.45---
Loss (Gain) on Equity Investments
-1.63---
Stock-Based Compensation
5.244.391.431.240.75
Other Operating Activities
-0.36-17.496.743.18-
Change in Accounts Payable
-1.58-1.042.03-1.241.1
Change in Unearned Revenue
---25.8525.85-
Change in Other Net Operating Assets
-6.27-8.5950.132.342.58
Operating Cash Flow
-54.08-67.72-18.68-10.96-32.98
Capital Expenditures
-0.06-0.08-0.01-2.49-0.16
Sale of Property, Plant & Equipment
---0.02-
Investment in Securities
1020---
Investing Cash Flow
9.9419.93-0.01-2.47-0.16
Long-Term Debt Issued
-75.530-
Long-Term Debt Repaid
---5.2--
Net Debt Issued (Repaid)
-44.4470.330-
Issuance of Common Stock
1.3143.690.110.070.12
Other Financing Activities
44.4444.44---
Financing Cash Flow
1.3195.140.4130.0720.11
Net Cash Flow
-42.8347.35-18.2816.65-13.03
Free Cash Flow
-54.14-67.79-18.68-13.44-33.14
Free Cash Flow Margin
----202.10%-
Free Cash Flow Per Share
-4.45-7.02-53.52-1.91-5.12
Levered Free Cash Flow
-36.65-37.95-41.84-8.73-
Unlevered Free Cash Flow
-35.59-37.27-40.68-8.83-
Change in Working Capital
-7.84-9.6426.3226.943.68
Updated Aug 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q